-
Most Recent
Search Results
240 results for FTE
T-Mobile – The Unscrupulous ‘Un-carrier’? (TMUS)
Cramming schemes with third parties who billed customers for unauthorized premium SMS text messages has T-Mobile in hot water with the FTC.
Short China Now
The ProShares UltraShort FTSE/Xinhua China 25 (NYSE: FXP) is on the verge of issuing a buy signal.
4 REIT ETFs for Dividend Seekers
Here are four REIT ETFs that offer attractive yields, diversified exposure to the real estate market and lower management fees than REIT mutual funds.
Is Qualcomm Stock Worth the FTC Risk of Being Long?
Qualcomm stock surged after its deal with Apple, then the FTC made a crushing ruling. Where does QCOM stock stand now?
Fantom (FTM) Price Predictions: How High Can a Gemini Listing Take the FTM Crypto?
Here are some of the Fantom (FTM) price predictions for investors interested in this decentralized finance crypto option right now.
FTX’s Sam Bankman-Fried Lands in FBI Hands as His Partners Take Plea Deals
FTX founder Sam Bankman-Fried is being abandoned by his partners, who are taking plea deals as he comes under FBI custody.
FTX Alert: 10 Things to Know as Binance Offers to Buy Sam Bankman-Fried’s FTX
Binance CEO Changpeng Zhao has offered to buy FTX as the company faces a liquidity crunch. The offer is non-binding and can be withdrawn.
DTE Stock Earnings: DTE Energy Beats EPS, Beats Revenue for Q2 2024
DTE stock results show that DTE Energy beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
FATE Stock Earnings: Fate Therapeutics Beats EPS, Beats Revenue for Q2 2024
FATE stock results show that Fate Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
DTE Stock Earnings: DTE Energy Misses EPS, Misses Revenue for Q1 2024
DTE stock results show that DTE Energy missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
FATE Stock Earnings: Fate Therapeutics Beats EPS, Beats Revenue for Q1 2024
FATE stock results show that Fate Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Kellogg Criticized for Misleading Cereal Ads (K, GIS, KFT)
Kellogg Co. (K) has had a difficult go of things in the wake of the recession, lagging rival packaged foods companies in the industries as…
Rite Aid Corporation (RAD) Stock Boosted by Buoyed Buyout Hopes
The Rite Aid (RAD) merger with Walgreens (WBA) is on shaky ground, but reaffirmation from Fred’s (FRED) helped give RAD stock a lift Thursday.
Adobe Stock Analysis: Why Investors May Want to Wait for the Fall to $500
Adobe’s AI-driven future is promising, yet valuation and legal risks mean waiting for a short-term pullback to create a good entry point.
Do You Have Hedge Fund Envy? Don’t!
The gargantuan growth of assets going into hedge funds is far more impressive than their actual returns. Don’t get reeled in by the hype.
Don’t Give Up on Rite Aid Corporation (RAD) Stock Now
It’s looking like the bottom is finally in for RAD stock. Here’s how things look for Rite Aid amid the new Walgreens deal.
FTX On Defense as U.S. Trustees, Sam Bankman-Fried Slam Legal Counsel
FTX’s legal counsel during its bankruptcy proceedings is under fire from both trustees and Sam Bankman-Fried himself.
T-Mobile Banking: 10 Things to Know About the New App
The new T-Mobile banking (TMUS) offering provides consumers with checking accounts with no monthly fees, overdraft fees or other charges.
Best Stocks Update: Energy Transfer Equity LP (ETE) Is Back in the Running
Energy Transfer Equity (ETE) stock is surging higher today heading into a ruling that could see ETE soar even further.
8 – 10 of 240 results
